KORU Medical Systems, Inc.

KRMD Nasdaq CIK: 0000704440

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 100 CORPORATE DRIVE, MAHWAH, NJ, 07430
Mailing Address 100 CORPORATE DRIVE, MAHWAH, NJ, 07430
Phone 845-469-2042
Fiscal Year End 1231
EIN 133044880

Financial Overview

FY2025 FY

$41.13M
Revenue
-$2.64M
Net Income
$28.20M
Total Assets

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events April 3, 2026 View on SEC
4 Insider stock transaction report April 1, 2026 View on SEC
4 Insider stock transaction report April 1, 2026 View on SEC
4 Insider stock transaction report April 1, 2026 View on SEC
4 Insider stock transaction report April 1, 2026 View on SEC
4 Insider stock transaction report April 1, 2026 View on SEC
4 Insider stock transaction report April 1, 2026 View on SEC
4 Insider stock transaction report March 18, 2026 View on SEC
4 Insider stock transaction report March 18, 2026 View on SEC
4 Insider stock transaction report March 18, 2026 View on SEC

Annual Reports

10-K March 12, 2026
  • Significantly advanced next-generation pump system, completing design freeze and beginning V&V testing, with FDA 510(k) submission targeted for Q3 2026.
  • Secured a new supply agreement with a leading biopharmaceutical company to co-promote infusion systems alongside a newly approved SCIg therapy.
View Analysis

Material Events

8-K Leadership Change March 16, 2026
High Impact
  • KORU Medical Systems appoints Adam Kalbermatten as new President and incoming CEO.
  • Kalbermatten brings strong medical device industry experience from Medtronic and Johnson & Johnson.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.